EVOK — Evoke Pharma Share News
0.000.00%
Last trade - 00:00- $18.86m
- $12.28m
- $10.25m
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Evoke Pharma Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038
Evoke Pharma Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Evoke Pharma Q1 Operating Expenses USD 4.4 Million
Evoke Pharma Inc expected to post a loss of 33 cents a share - Earnings Preview
Evoke Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Evoke Pharma Inc expected to post a loss of 63 cents a share - Earnings Preview
Evoke Pharma Inc reports results for the quarter ended September 30 - Earnings Summary
Evoke Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Monte Rosa, EyePoint Pharma, Shake Shack
Brief: Evoke Pharma & Eversana Announce Statistically Significant Improvement In Patient Outcomes For Glp-1 Users With Diabetic Gastroparesis Using Gimoti®
Evoke surges on positive study for nasal spray
Brief: Evoke Pharma Enters Seventh Amendment To Lease Agreement With SB Corporate Centre III-IV, LLC
Bookmaker Evoke's shares up on acquisition of Romania-based Winner.ro